HomeInsightsStock Comparison

Divis Laboratories Ltd vs Kobo Biotech Ltd Stock Comparison

Divis Laboratories Ltd vs Kobo Biotech Ltd Stock Comparison

Last Updated on: Jun 22, 2025

Key Highlights

  • The Latest Trading Price of Divis Laboratories Ltd is ₹ 6589 as of 20 Jun 15:30.
  • The P/E Ratio of Divis Laboratories Ltd changed from 38.3 on March 2020 to 56.9 on March 2024 . This represents a CAGR of 8.24% over 5 yearsThe P/E Ratio of Kobo Biotech Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Divis Laboratories Ltd changed from ₹ 52763 crore on March 2020 to ₹ 91234 crore on March 2024 . This represents a CAGR of 11.57% over 5 yearsThe Market Cap of Kobo Biotech Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Divis Laboratories Ltd for the Mar '25 is ₹ 2671 crore as compare to the Dec '24 revenue of ₹ 2401 crore. This represent the growth of 11.25% The revenue of Kobo Biotech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Divis Laboratories Ltd for the Mar '25 is ₹ 971 crore as compare to the Dec '24 ebitda of ₹ 825 crore. This represent the growth of 17.7% The ebitda of Kobo Biotech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Divis Laboratories Ltd changed from ₹ 356 crore to ₹ 662 crore over 8 quarters. This represents a CAGR of 36.37% The net profit of Kobo Biotech Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Divis Laboratories Ltd changed from 33.04 % on March 2020 to 50.44 % on March 2024 . This represents a CAGR of 8.83% over 5 yearsThe Dividend Payout of Kobo Biotech Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Divis Laboratories Ltd

  • Divi's Laboratories Limited is one of the leading pharmaceutical companies in the world, manufacturing Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceuticals.
  • The Company is one of the world's largest API companies, with two manufacturing units and a market presence across 100 countries.
  • It is engaged in the manufacture of Active Pharmaceutical ingredients (API's), Intermediates and Nutraceutical ingredients with predominance in exports.
  • In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.
  • It is among the largest pharmaceutical companies in India with a portfolio of approx.

About Kobo Biotech Ltd

  • Kobo Biotech Ltd.(Formerly known Avon Lifesciences Ltd) was established as a Public Limited Company on August 3, 1992.
  • Effective 19th October, 2020, the Company's name was changed to Kobo Biotech Limited from erstwhile Avon Lifesciences Limited.
  • The Company is a customer-centric manufacturer of active pharmaceutical ingredients (API).Promoted by P R Agarwal, Rajesh Agarwal and G S Sidhu, the Company manufacture diketene and its derivatives Monomethyl Acetoncetamide(MMA) and Methyl Acetoacetate(MAA). The company's 1200 tpa Diketene manufacturing faciltiy located at Sadashivpet in Andhrapradesh and the products of it were used in pigments, pharmaceuticals and pesticides. The company has a tripartite technical knowhow agreement with Shanghai Machinery & Equipment Import and Export Corporation (SMEC), representative of Shanghai Peng Pu Chemical Works (SPCW) and Xytel Technologies Partnership (XTP), US.

Divis Laboratories Ltd News Hub

News

Divis Laboratories Ltd up for third consecutive session

Divis Laboratories Ltd is up for a third straight session today. The stock is quoting at R...

Read more

11 Jun 2025 13:05

News

Divis Laboratories Ltd down for fifth straight session

Divis Laboratories Ltd is down for a fifth straight session today. The stock is quoting at...

Read more

02 Jun 2025 13:35

News

Divis Lab inks long-term global pharma deal

As part of the agreement, Divis will manufacture and supply advanced pharmaceutical interm...

Read more

24 May 2025 10:06

News

Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co.

Divis Laboratories has entered into a long term manufacturing and supply agreement with a ...

Read more

24 May 2025 11:34

News

Divis Lab gains after Q4 PAT climbs 23% YoY; recommends final dividend of Rs 30/ share

Revenue from operations grew by 12.24% year on year (YoY) to Rs 2,585 crore in the quarter...

Read more

19 May 2025 10:00

News

Divis Laboratories to convene AGM

Divis Laboratories announced that the 35th Annual General Meeting(AGM) of the company will...

Read more

19 May 2025 17:49

Kobo Biotech Ltd News Hub

News

Kobo Biotech to discuss results

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 14 August 202...

Read more

13 Aug 2024 10:21

News

Kobo Biotech to convene board meeting

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 30 May 2024 P...

Read more

28 May 2024 15:31

News

Kobo Biotech to conduct board meeting

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 14 February 2...

Read more

09 Feb 2024 14:57

News

Kobo Biotech to hold board meeting

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 10 November 2...

Read more

03 Nov 2023 17:17

News

Kobo Biotech to hold AGM

Kobo Biotech announced that the 30th Annual General Meeting (AGM) of the company will be h...

Read more

09 Sep 2023 18:44

News

Kobo Biotech to declare Quarterly Result

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 11 August 202...

Read more

07 Aug 2023 13:02

SWOT Analysis Of Divis Laboratories Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Kobo Biotech Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Divis Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Kobo Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Divis Laboratories Ltd and Kobo Biotech Ltd

Which company has a larger market capitalization, Divis Laboratories Ltd or Kobo Biotech Ltd?

Market cap of Divis Laboratories Ltd is 174,939 Cr while Market cap of Kobo Biotech Ltd is 5 Cr

What are the key factors driving the stock performance of Divis Laboratories Ltd and Kobo Biotech Ltd?

The stock performance of Divis Laboratories Ltd and Kobo Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Divis Laboratories Ltd and Kobo Biotech Ltd?

As of June 22, 2025, the Divis Laboratories Ltd stock price is INR ₹6589.85. On the other hand, Kobo Biotech Ltd stock price is INR ₹2.45.

How do dividend payouts of Divis Laboratories Ltd and Kobo Biotech Ltd compare?

To compare the dividend payouts of Divis Laboratories Ltd and Kobo Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions